LUMOS PHARMA, INC. Annual Nonoperating Income (Expense) in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Lumos Pharma, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2015 to 2023.
  • Lumos Pharma, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $272K, a 60.2% decline year-over-year.
  • Lumos Pharma, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $1.87M, a 16.7% decline year-over-year.
  • Lumos Pharma, Inc. annual Nonoperating Income (Expense) for 2023 was $2.55M, a 164% increase from 2022.
  • Lumos Pharma, Inc. annual Nonoperating Income (Expense) for 2022 was $965K, a 243% increase from 2021.
  • Lumos Pharma, Inc. annual Nonoperating Income (Expense) for 2021 was $281K, a 95.8% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.55M +$1.59M +164% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $965K +$684K +243% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $281K -$6.39M -95.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-07
2020 $6.67M +$6.56M +5906% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2019 $111K -$1.76M -94.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
2018 $1.88M +$1.5M +405% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-03
2017 $371K +$124K +50.2% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-03
2016 $247K +$288K Jan 1, 2016 Dec 31, 2016 10-K 2019-03-05
2015 -$41K Jan 1, 2015 Dec 31, 2015 10-K 2018-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.